UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 325

Sortiert nach

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial

JAMA : the journal of the American Medical Association, 2005-10, Vol.294 (13), p.1625

2005

Volltextzugriff (PDF)

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial

JAMA : the journal of the American Medical Association, 2013-03, Vol.309 (12), p.1268

2013

Volltextzugriff (PDF)

Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study

Circulation (New York, N.Y.), 2015-05, Vol.131 (20), p.1763-1771

2015

Volltextzugriff (PDF)

Prognostic significance of anemia in women with suspected ischemia, an insight from the women ischemia syndrome evaluation study (WISE)

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome

The New England journal of medicine, 2012-12, Vol.367 (24), p.2296-2304

2012

Volltextzugriff (PDF)

Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials

JAMA : the journal of the American Medical Association, 2005-10, Vol.294 (13), p.1664

2005

Volltextzugriff (PDF)

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease

Journal of the American College of Cardiology, 2006-02, Vol.47 (3 Suppl), p.S21-S29

2006

Volltextzugriff (PDF)

Acute heart failure syndromes : Current state and framework for future research

Circulation, 2005-12, Vol.112 (25), p.3958-3968

2005

Volltextzugriff (PDF)

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies

Journal of the American College of Cardiology, 2006-02, Vol.47 (3 Suppl), p.S4-S20

2006

Volltextzugriff (PDF)

Persistent chest pain at 1-year predicts long-term angina hospitalization in women with and without obstructive coronary artery disease: results from Women's Ischemia Syndrome Evaluation (WISE)

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial

Circulation (New York, N.Y.), 1991-02, Vol.83 (2), p.448-459

1991

Volltextzugriff (PDF)

Role of physical fitness in the obesity paradox. Long-term major adverse cardiovascular events in the Women's Ischemia Syndrome Evaluation (WISE)

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Resuscitation outcomes consortium roc primed trial of early rhythm analysis versus later analysis in out-of-hospital cardiac arrest

Resuscitation, 2010-12, Vol.81 (2), p.S16-S16

2010

Volltextzugriff (PDF)

The resuscitation outcomes consortium (ROC) primed impedance threshold device (ITD) cardiac arrest trial: A prospective, randomised, double-blind, controlled clinical trial

Resuscitation, 2010-12, Vol.81 (2), p.S22-S22

2010

Volltextzugriff (PDF)

Women and cardiovascular heart disease: clinical implications from the Women's Ischemia Syndrome Evaluation (WISE) Study. Are we smarter?

Journal of the American College of Cardiology, 2006-02, Vol.47 (3 Suppl), p.S59-S62

2006

Volltextzugriff (PDF)

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

Annals of internal medicine, 1991-08, Vol.115 (4), p.256

1991

Volltextzugriff (PDF)

Association between β-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women : a report from the NHLBI-sponsored WISE study

International Journal of Obesity, 2005-07, Vol.29 (7), p.746-754

2005

Volltextzugriff (PDF)

Depression, the metabolic syndrome and cardiovascular risk

Psychosomatic medicine, 2008-01, Vol.70 (1), p.40-48

2008

Volltextzugriff (PDF)

Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience

Neurology, 1995-04, Vol.45 (4), p.649

1995

Volltextzugriff (PDF)

Evidence-based guidelines for cardiovascular disease prevention in women

Circulation (New York, N.Y.), 2004-02, Vol.109 (5), p.672-693

2004

Volltextzugriff (PDF)

Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA : a report from the NHLBI PTCA registry

European heart journal, 1998, Vol.19 (1), p.103-111

1998

Volltextzugriff (PDF)

A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach

European heart journal, 2008-03, Vol.29 (6), p.816-824

2008

Volltextzugriff (PDF)

Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: Results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)

Circulation (New York, N.Y.), 2004-02, Vol.109 (6), p.722-725

2004

Volltextzugriff (PDF)

Some Thoughts on the Vasculopathy of Women With Ischemic Heart Disease

Journal of the American College of Cardiology, 2006-02, Vol.47 (3), p.S30-S35

2006

Volltextzugriff (PDF)

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)

Circulation (New York, N.Y.), 2004-02, Vol.109 (6), p.726-732

2004

Volltextzugriff (PDF)

1 – 25 von 325

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(285)

Publikationsform

Sprache

Englisch
(320)
Japanisch
(41)
Russisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(210)
Humans
(187)
Life Sciences & Biomedicine
(176)
Female
(141)
Biological And Medical Sciences
(122)
Medical Sciences
(119)
Cardiovascular System & Cardiology
(112)
Middle Aged
(109)
Cardiac & Cardiovascular Systems
(108)
Male
(92)
Cardiology. Vascular System
(70)
Aged
(68)
Heart
(61)
Coronary Heart Disease
(46)
Adult
(44)
Risk Factors
(44)
Peripheral Vascular Disease
(41)
Cardiovascular Disease
(36)
Coronary Angiography
(36)
Physics
(36)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial

Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study

Prognostic significance of anemia in women with suspected ischemia, an insight from the women ischemia syndrome evaluation study (WISE)

Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome

Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease

Acute heart failure syndromes : Current state and framework for future research

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies

Persistent chest pain at 1-year predicts long-term angina hospitalization in women with and without obstructive coronary artery disease: results from Women's Ischemia Syndrome Evaluation (WISE)

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial

Role of physical fitness in the obesity paradox. Long-term major adverse cardiovascular events in the Women's Ischemia Syndrome Evaluation (WISE)

Resuscitation outcomes consortium roc primed trial of early rhythm analysis versus later analysis in out-of-hospital cardiac arrest

The resuscitation outcomes consortium (ROC) primed impedance threshold device (ITD) cardiac arrest trial: A prospective, randomised, double-blind, controlled clinical trial

Women and cardiovascular heart disease: clinical implications from the Women's Ischemia Syndrome Evaluation (WISE) Study. Are we smarter?

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

Association between β-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women : a report from the NHLBI-sponsored WISE study

Depression, the metabolic syndrome and cardiovascular risk

Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience

Evidence-based guidelines for cardiovascular disease prevention in women

Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA : a report from the NHLBI PTCA registry

A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach

Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: Results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)

Some Thoughts on the Vasculopathy of Women With Ischemic Heart Disease

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)

Suchergebnisse filtern